Acquires facility in Feasterville, PA, launches cleanroom in Suzhou, China and expands cleanroom manufacturing in Venray, The Netherlands
Oliver-Tolas Healthcare Packaging has expanded its global operations with the acquisition of a facility in Feasterville, PA, US, an expansion of the cleanroom manufacturing area in Venray, The Netherlands facility and the launch of manufacturing in Suzhou, China.
The newly acquired 50,000ft2 facility is adjacent to Oliver-Tolas' current Feasterville, PA operation at Pennsylvania Boulevard. ‘We have been deliberating expansion options for our Feasterville, PA operation and are excited to have overcome space limitations,’ said Jerry Bennish, President and CEO.
‘Utilisation of the additional warehouse space has begun and plans are underway to construct an ISO 7 and an ISO 8 cleanroom totalling 5,000ft2.’
The Feasterville operation manufactures pouches, roll stock, lids and zone-coated lids. The firm says the expansion will allow for improved product flow, added capacity and additional cleanroom space.
Oliver-Tolas plans to continue investment at the plant with equipment to support increasing demand for high-quality sterile-grade packaging.
The expansion of the cleanroom manufacturing area in Venray includes a 1,300ft2 ISO 8 certified cleanroom and 16,000ft2 warehouse.
‘The expansion demonstrates Oliver-Tolas' commitment to the European sterile-grade packaging market,’ said Rutger van Dooren, International Managing Director.
The expansion demonstrates Oliver-Tolas' commitment to the European sterile-grade packaging market
Oliver-Tolas currently produces lids and pouches using its Xhale and SealScience adhesive coated products at the Venray facility. The added space will be used for the preparation of printed roll stock products and additional capacity for lid production.
The firm opened a sales office in Suzhou, China in 2006 to support demand for medical device and pharmaceutical manufacturing and is now bringing die-cut lid manufacturing to China paired with its core adhesive technologies.
‘This allows Oliver-Tolas to improve and localise service to existing customers in the region and support demand from medical device and pharmaceutical manufacturers moving into China,’ said Jeff Murak, Vice President of Sales and Marketing.
The 12,000ft2 facility includes an 1,800ft2 registered ISO 8 cleanroom.
This announcement comes a year after Oliver-Tolas made a US$1.3m investment at its Grand Rapids, Michigan, US facility. The investment included a manufacturing area expansion, additional cleanroom installations and the modernisation and expansion of a Packaging Development and Technology Centre.
The manufacturing area expansion added 40,000ft2 to the existing 140,000ft2 of production space.